Test Bank For Davis's Drug Guide for Nurses 19th Edition by April Hazard Vallerand PhD, RN, FAAN, Cynthia A. Sanoski | Latest Complete Guide A+

Test Bank For Davis's Drug Guide for Nurs
3f 3f 3f 3f 3f 3f 3f


es Eighteenth Edition
3f 3f




by3fApril3fHazard3fVallerand3fPhD,3fRN,3fFAAN,3fCynthia3fA.3fSanoski


@2024

,How3fTo3fUse3fDavis’s3fDrug3fGuide3fFor3fNurses
Davis's3fDrug3fGuide3ffor3fNurses3fby3fApril3fHazard3fVallerand



1. What3fis3fthe3fprimary3fpurpose3fof3fDavis’s3fDrug3fGuide3ffor3fNurses?

 a.3fTo3fprovide3flegal3fguidelines3ffor3fdrug3fadministration
 b.3fTo3fserve3fas3fa3fcomprehensive3freference3ffor3fdrug3finformation
 c.3fTo3foffer3fa3flist3fof3fmedications3fcovered3fby3finsurance
 d.3fTo3freplace3fclinical3fjudgment3fin3fmedication3fadministration
ANS:3fB
Rationale:3fThe3fprimary3fpurpose3fof3fDavis’s3fDrug3fGuide3fis3fto3fserve3fas3f
a3fcomprehensive3freference3ffor3fnurses,3fproviding3fdetailed3finformation3fab
out3fdrug3factions,3finteractions,3fside3feffects,3fand3fnursing3fconsiderations3fto3f
ensure3fsafe3fand3feffective3fmedication3fadministration.

2. Which3fsection3fof3fDavis’s3fDrug3fGuide3fwould3fyou3fconsult3ffor3fa3fdr
ug’s3fpharmacokinetics?

 a.3fDrug3finteractions
 b.3fAdministration3fguidelines
 c.3fDrug3fclassification
 d.3fPharmacology
ANS:3fD
Rationale:3fThe3fpharmacology3fsection3fprovides3fessential3fdetails3fabout3fthe
3fdrug’s3fpharmacokinetics,3fincluding3fabsorption,3fdistribution,3fmetabolism,3f

and3fexcretion,3fwhich3fare3fcrucial3ffor3funderstanding3fhow3fthe3fdrug3fworks3fi
n3fthe3fbody.

3. Where3fcan3fyou3ffind3finformation3fabout3fcommon3fside3feffects3f
of3fa3fmedication?

 a.3fDosage3fand3fadministration
 b.3fContraindications
 c.3fAdverse3freactions
 d.3fDrug3finteractions
ANS:3fC
Rationale:3fThe3fadverse3freactions3fsection3flists3fcommon3fside3feffects

, associated3fwith3fthe3fmedication,3fhelping3fnurses3fanticipate3fand3fmanage3fpo
tential3fcomplications3fduring3ftherapy.

4. If3fa3fnurse3fneeds3fto3fknow3fthe3frecommended3fdosage3ffor3fa3fspecific3fpa
tient3fpopulation,3fwhich3fsection3fshould3fthey3fconsult?

 a.3fDosage3fand3fadministration
 b.3fPharmacology
 c.3fNursing3fimplications
 d.3fPatient3feducation
ANS:3fA
Rationale:3fThe3fdosage3fand3fadministration3fsection3fprovides3fspecific3fdosin
g3frecommendations3fbased3fon3fage,3fweight,3frenal3ffunction,3fand3fother3fpatie
nt-3fspecific3ffactors,3fensuring3fappropriate3fmedication3fadministration.

5. What3ftype3fof3finformation3fis3fincluded3fin3fthe3f“Nursing3fImplications”3fsection?

 a.3fLegal3frequirements3ffor3fprescribing3fmedication
 b.3fPatient3feducation3fand3fmonitoring3fconsiderations
 c.3fHistorical3fbackground3fof3fthe3fdrug
 d.3fCost3fanalysis3fof3fthe3fmedication
ANS:3fB
Rationale:3fThe3fnursing3fimplications3fsection3fincludes3fessential3finformatio
n3fon3fwhat3fnurses3fshould3fmonitor,3fpotential3fside3feffects3fto3fwatch3ffor,3fan
d3fguidance3fon3fpatient3feducation3fto3fenhance3fsafety3fand3fefficacy3fin3fdrug3f
administration.

6. Which3fof3fthe3ffollowing3fis3fa3fkey3fbenefit3fof3fusing3fDavis’s3fDrug3fGuide?

 a.3fIt3fis3favailable3fin3fmultiple3flanguages
 b.3fIt3fcontains3fonly3fthe3fmost3fcommonly3fprescribed3fmedications
 c.3fIt3fprovides3fup-to-date3fdrug3finformation3ffor3fclinical3fpractice
 d.3fIt3freplaces3fthe3fneed3ffor3fongoing3feducation3fin3fpharmacology
ANS:3fC
Rationale:3fDavis’s3fDrug3fGuide3foffers3fup-to-
date3fdrug3finformation,3freflecting3fcurrent3fclinical3fpractice,3fwhich3fis3fessen
tial3ffor3fsafe3fmedication3fadministration3fand3fnursing3fcare.

7. When3fusing3fthe3fguide,3fhow3fcan3fnurses3fensure3fthey3fare3finterpreting3f
drug3finteractions3fcorrectly?

,  a.3fBy3fonly3fconsulting3fthe3fdrug3finteractions3fsection
 b.3fBy3fcross-referencing3fwith3fother3fpharmacology3ftexts
 c.3fBy3ffocusing3fsolely3fon3fcommon3finteractions
 d.3fBy3funderstanding3fthe3funderlying3fmechanisms3fof3finteractions
ANS:3fD
Rationale:3fUnderstanding3fthe3funderlying3fmechanisms3fof3fdrug3finteractions
3fallows3fnurses3fto3finterpret3fpotential3frisks3fand3fpatient-

specific3ffactors3faccurately,3fensuring3fsafe3fmedication3fpractices.

8. How3fshould3fa3fnurse3fapproach3fa3fsituation3fwhere3fa3fdrug3fis3fcontraindic
ated3ffor3fa3fpatient?

 a.3fAdminister3fthe3fdrug3fwith3fcaution
 b.3fDiscuss3falternative3fmedications3fwith3fthe3fhealthcare3fprovider
 c.3fIgnore3fthe3fcontraindication3fif3fthe3fpatient3finsists
 d.3fEducate3fthe3fpatient3fabout3fthe3fdrug's3fbenefits3fonly
ANS:3fB
Rationale:3fIf3fa3fdrug3fis3fcontraindicated,3fthe3fnurse3fshould3fdiscuss3falternat
ive3fmedications3fwith3fthe3fhealthcare3fprovider3fto3fensure3fpatient3fsafety3fan
d3fappropriate3ftreatment.

9. What3fis3fthe3fsignificance3fof3fthe3f“Patient3fEducation”3fsection3fin3fthe3fd
rug3fguide?

 a.3fIt3fprovides3fdetailed3fpharmaceutical3fresearch
 b.3fIt3femphasizes3fthe3fimportance3fof3fnurse-patient3fcommunication
 c.3fIt3fcontains3finstructions3ffor3fmedication3fstorage
 d.3fIt3fis3fnot3frelevant3ffor3fnursing3fpractice
ANS:3fB
Rationale:3fThe3fpatient3feducation3fsection3femphasizes3fthe3fimportance3fof3fcl
ear3fcommunication,3fhelping3fnurses3feducate3fpatients3fabout3ftheir3fmedicatio
ns,3fincluding3findications,3fside3feffects,3fand3fadherence3fstrategies.

10. In3fwhich3fsection3fwould3fyou3ffind3finformation3fabout3fspecial3fpopulatio
ns,3fsuch3fas3fpregnant3for3fpediatric3fpatients?

 a.3fNursing3fimplications
 b.3fDosage3fand3fadministration
 c.3fPharmacology
 d.3fSpecial3fpopulations
ANS:3fD